There is little doubt that we are in the midst of a worldwide epidemic of diabetes. Insulin resistance, defined by the inability to respond to normal circulating levels of insulin, is recognized as a characteristic trait of the disease, most often occurring in obese patients. Emerging data suggests an inflammatory link between obesity and diabetes. However, understanding the specific lesions that cause insulin resistance in patients with Type 2 diabetes will first require a better grasp of the cell biology of insulin action, and the interplay between the innate immune system and insulin action. To this end, the molecular events involved in the regulation of glucose uptake by insulin will be investigated, with special attention to the underlying basis for the specificity of actions of the hormone.
Aim 1 will evaluate molecular mechanisms responsible for improved insulin sensitivity in the face of a high fat diet in mice with a targeted deletion in the CAP gene. We will evaluate the migration and activation of adipose tissue macrophages in these mice, and perform in vitro studies to elucidate the molecular defects in these cells resulting from CAP knockout.
In Aim 2 the action of CAP in adipocytes will be studied, with particular attention to its role in supporting Cbl phosphorylation and downstream signaling, and in assembling actin-based complexes at the plasma membrane.
Aim 3 will focus on the CAP family member Vinexin, and its genetic interactions with CAP. We will study mice with a targeted deletion in the Vinexin gene, and cross these with CAPKO mice, to elucidate the role of this family of proteins in the regulation of glucose homeostasis. Together, these approaches will allow for the evaluation of the importance of this novel pathway in insulin action, setting the stage for future investigations into its potential role in the development of diabetes.

Public Health Relevance

There is little doubt that we are in the midst of a worldwide epidemic of diabetes. Insulin resistance, defined by the inability to respond to normal circulating levels of insulin, is recognized as a characteristic trait of the disease, most often occurring in obese patients. Emerging data suggests an inflammatory link between obesity and diabetes. We will strive to understand the specific lesions that cause insulin resistance in patients with Type 2 diabetes by first gaining a better grasp of the cell biology of insulin action, and the interplay between the innate immune system and insulin action.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK060591-10
Application #
8244559
Study Section
Integrative Physiology of Obesity and Diabetes Study Section (IPOD)
Program Officer
Abraham, Kristin M
Project Start
2002-02-01
Project End
2013-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
10
Fiscal Year
2012
Total Cost
$314,290
Indirect Cost
$98,668
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Hochberg, Irit; Harvey, Innocence; Tran, Quynh T et al. (2015) Gene expression changes in subcutaneous adipose tissue due to Cushing's disease. J Mol Endocrinol 55:81-94
Reilly, Shannon M; Ahmadian, Maryam; Zamarron, Brian F et al. (2015) A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesis. Nat Commun 6:6047
Fang, Sungsoon; Suh, Jae Myoung; Reilly, Shannon M et al. (2015) Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nat Med 21:159-65
Bridges, Dave; Saltiel, Alan R (2015) Phosphoinositides: Key modulators of energy metabolism. Biochim Biophys Acta 1851:857-66
Reilly, Shannon M; Saltiel, Alan R (2014) Obesity: A complex role for adipose tissue macrophages. Nat Rev Endocrinol 10:193-4
Wang, Guo-Xiao; Cho, Kae Won; Uhm, Maeran et al. (2014) Otopetrin 1 protects mice from obesity-associated metabolic dysfunction through attenuating adipose tissue inflammation. Diabetes 63:1340-52
Reilly, Shannon M; Saltiel, Alan R (2014) Countering inflammatory signals in obesity. Nat Immunol 15:410-1
Lu, Binbin; Bridges, Dave; Yang, Yemen et al. (2014) Metabolic crosstalk: molecular links between glycogen and lipid metabolism in obesity. Diabetes 63:2935-48
Reilly, Shannon M; Chiang, Shian-Huey; Decker, Stuart J et al. (2013) An inhibitor of the protein kinases TBK1 and IKK-É› improves obesity-related metabolic dysfunctions in mice. Nat Med 19:313-21
Mowers, Jonathan; Uhm, Maeran; Reilly, Shannon M et al. (2013) Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKKε and TBK1. Elife 2:e01119

Showing the most recent 10 out of 33 publications